JOHNSON + JOHNSON DL 1JOHNSON + JOHNSON DL 1JOHNSON + JOHNSON DL 1

JOHNSON + JOHNSON DL 1

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪334.35 B‬EUR
5.48EUR
‪12.84 B‬EUR
‪77.15 B‬EUR
‪2.40 B‬
Beta (1Y)
0.00
Employees (FY)
‪131.9 K‬
Change (1Y)
‪−20.8 K‬ −13.62%
Revenue / Employee (1Y)
‪584.90 K‬EUR
Net income / Employee (1Y)
‪91.54 K‬EUR

About Johnson & Johnson


CEO
Joaquin Duato
Headquarters
New Brunswick
Website
Founded
1887
FIGI
BBG000DS2SB7
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US478160CT9
JOHNSON&JOHN 20/60
Yield to maturity
6.82%
Maturity date
Sep 1, 2060
US478160CS1
JOHNSON&JOHN 20/50
Yield to maturity
6.78%
Maturity date
Sep 1, 2050
US478160CJ1
JOHNSON & JOHNSON 17/25
Yield to maturity
6.61%
Maturity date
Jan 15, 2025
US478160CR3
JOHNSON&JOHN 20/40
Yield to maturity
6.40%
Maturity date
Sep 1, 2040
US478160CM4
JOHNSON & JOHNSON 17/48
Yield to maturity
6.11%
Maturity date
Jan 15, 2048
US478160BV5
JOHNSON & JOHNSON 16/46
Yield to maturity
6.00%
Maturity date
Mar 1, 2046
JNJJ
JOHNSON & JOHNSON 17/47
Yield to maturity
5.97%
Maturity date
Mar 3, 2047
US478160CL6
JOHNSON & JOHNSON 17/38
Yield to maturity
5.64%
Maturity date
Jan 15, 2038
US478160CF9
JOHNSON & JOHNSON 17/37
Yield to maturity
5.48%
Maturity date
Mar 3, 2037
US478160CX0
JOHNSON&JOHN 24/54
Yield to maturity
5.42%
Maturity date
Jun 1, 2054
US478160BU7
JOHNSON & JOHNSON 16/36
Yield to maturity
5.42%
Maturity date
Mar 1, 2036

Explore more bonds 

Frequently Asked Questions


The current price of JNJ is 138.24 EUR — it has decreased by −0.50% in the past 24 hours. Watch JOHNSON + JOHNSON DL 1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange JOHNSON + JOHNSON DL 1 stocks are traded under the ticker JNJ.
JNJ stock has fallen by −1.05% compared to the previous week, the month change is a −7.21% fall, over the last year JOHNSON + JOHNSON DL 1 has showed a −1.54% decrease.
We've gathered analysts' opinions on JOHNSON + JOHNSON DL 1 future price: according to them, JNJ price has a max estimate of 204.73 EUR and a min estimate of 151.40 EUR. Watch JNJ chart and read a more detailed JOHNSON + JOHNSON DL 1 stock forecast: see what analysts think of JOHNSON + JOHNSON DL 1 and suggest that you do with its stocks.
JNJ reached its all-time high on Jul 12, 2022 with the price of 178.26 EUR, and its all-time low was 36.34 EUR and was reached on Mar 19, 2009. View more price dynamics on JNJ chart.
See other stocks reaching their highest and lowest prices.
JNJ stock is 0.81% volatile and has beta coefficient of 0.00. Track JOHNSON + JOHNSON DL 1 stock price on the chart and check out the list of the most volatile stocks — is JOHNSON + JOHNSON DL 1 there?
Today JOHNSON + JOHNSON DL 1 has the market capitalization of ‪334.35 B‬, it has decreased by −0.13% over the last week.
Yes, you can track JOHNSON + JOHNSON DL 1 financials in yearly and quarterly reports right on TradingView.
JOHNSON + JOHNSON DL 1 is going to release the next earnings report on Jan 22, 2025. Keep track of upcoming events with our Earnings Calendar.
JNJ earnings for the last quarter are 2.17 EUR per share, whereas the estimation was 1.98 EUR resulting in a 9.68% surprise. The estimated earnings for the next quarter are 1.94 EUR per share. See more details about JOHNSON + JOHNSON DL 1 earnings.
JOHNSON + JOHNSON DL 1 revenue for the last quarter amounts to ‪20.18 B‬ EUR, despite the estimated figure of ‪19.91 B‬ EUR. In the next quarter, revenue is expected to reach ‪21.59 B‬ EUR.
JNJ net income for the last quarter is ‪2.42 B‬ EUR, while the quarter before that showed ‪4.37 B‬ EUR of net income which accounts for −44.69% change. Track more JOHNSON + JOHNSON DL 1 financial stats to get the full picture.
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.18 EUR. As of today, Dividend Yield (TTM)% is 3.40%. Tracking JOHNSON + JOHNSON DL 1 dividends might help you take more informed decisions.
JOHNSON + JOHNSON DL 1 dividend yield was 3.00% in 2023, and payout ratio reached 84.93%. The year before the numbers were 2.52% and 66.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 24, 2024, the company has ‪131.90 K‬ employees. See our rating of the largest employees — is JOHNSON + JOHNSON DL 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JOHNSON + JOHNSON DL 1 EBITDA is ‪25.92 B‬ EUR, and current EBITDA margin is 34.82%. See more stats in JOHNSON + JOHNSON DL 1 financial statements.
Like other stocks, JNJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JOHNSON + JOHNSON DL 1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JOHNSON + JOHNSON DL 1 technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JOHNSON + JOHNSON DL 1 stock shows the sell signal. See more of JOHNSON + JOHNSON DL 1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.